Zomedica Announces Record Second Quarter 2023 Financial Results: Revenue up 43% to $6.0 Million; Strong 67% Gross Margin & $142.4 Million in LiquidityAccesswire • 08/10/23
Zomedica Launches Revolutionary TRUVIEW(TM) Digital Microscope with Advanced Optics, Automated Slide Preparation, and Telepathology ServicesAccesswire • 06/09/23
Zomedica Announces Record First Quarter 2023 Financial Results: Revenue up 45% to $5.5 Million; Strong 70% Gross Margin & $147.5 Million in LiquidityAccesswire • 05/11/23
Zomedica Corp. Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)Accesswire • 03/31/23
Zomedica Corporation Reports 2022 Results: $18.9 Million Revenue; 72% Gross Margin & $156 Million in Liquidity - Revenue up 361% from 2021 through combination of acquisitions and organic growthAccesswire • 03/15/23
Zomedica to Host Fourth Quarter and Fiscal Year 2022 Financial Results Call on March 15Accesswire • 03/08/23
Zomedica to Take Control of New Assay Development and Manufacturing of TRUFORMA Product Line through Long-Term Licensing Agreement with Qorvo BiotechnologiesAccesswire • 01/18/23